Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 14/20 | 0.49 |
| ▸ | CNR1 | P21554 | 5/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | TLR8 | Q9NR97 | 4/20 | 0.46 |
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30641152 | 0.86 | CNR2 (0.42) | CNR2CNR1SLC6A3BRD4CREBBP | |
| SCHEMBL17788575 | 0.83 | CNR2 (0.50) | CNR2CNR1 | |
| SCHEMBL4847027 | 0.80 | ALDH1A1 (0.58) | CNR2TLR8TP53 | |
| SCHEMBL10413633 | 0.80 | ALDH1A1 (0.58) | CNR2TLR8TP53 | |
| SCHEMBL11664571 | 0.80 | ALDH1A1 (0.58) | CNR2TLR8TP53 | |
| SCHEMBL8506252 | 0.79 | CNR2 (0.44) | CNR2CNR1SLC6A3TLR8 | |
| SCHEMBL11663572 | 0.79 | ALDH1A1 (0.60) | CNR2CNR1TLR8TP53 | |
| SCHEMBL21501948 | 0.77 | KDM4E (0.49) | CNR2CNR1SLC6A3TLR8TP53 | |
| SCHEMBL4854120 | 0.77 | CNR2 (0.45) | CNR2TLR8TP53 | |
| SCHEMBL11812516 | 0.77 | TP53 (0.49) | CNR2CNR1TLR8TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7388100-B2 | Tertiary amine compounds | NISHIO TETSUYA | 2008-06-17 | — | — | US | disclosed |
| US-20060145145-A1 | Tertiary amine compounds, organic semiconductor devices using the same and organic electroluminescence devices using the same | NISHIO TETSUYA | 2006-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060145145-A1 | Tertiary amine compounds, organic semiconductor devices using the same and organic electroluminescence devices using the same | PIEZO1, YES1, SAT1 | CNR2 4696/4885CNR1 4163/4885SLC6A3 599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.